Exploring Ketamine’s Expanding Roles Beyond Anesthesia, Including PTSD, Chronic Pain, and Depression Treatment
Pakistan Journal of Medical and Health Sciences December 28, 2023 Jawad Hameed, Roheena Wadud
In a retrospective observational study at a tertiary care hospital in Pakistan, 70 patients receiving ketamine for chronic pain, treatment-resistant depression, or PTSD showed substantial reductions in symptom severity. 78.5% of patients had positive responses with no adverse effects. Ketamine represents a viable and fast-acting alternative for refractory psychiatric and pain conditions.